Goodwin advised Sofinnova Partners, Intermediate Capital Group, Tekla et CTI Life Sciences. Jones Day advised Amolyt Pharma. McDermott Will & Emery advised Andera Partners, Novo Holdings…
- Homepage
- Europe
- Europe Legal Chronicle
- Amolyt Pharma’s EUR 138 Million Fund Raising
Amolyt Pharma’s EUR 138 Million Fund Raising
Tagged: 12-01-2023 Adrien Starck Amolyt Pharma Andera Partners Anne-Charlotte Rivière Anthony Paronneau CTI Life Sciences Fund Emily Tribulski EQT Life Sciences Félicien Bardsley Geoffroy Pineau-Valencienne Goodwin Procter InnoBio Intermediate Capital Group Plc Jones Day Julie Messerig Kristina Bieker Kurma Partners Lily Xu Louis de Chezelles Lucie Martin Marie Fillon Marie-Laure Bruneel McDermott Will & Emery Novo Holdings A Pavel Puzerey S Sofinnova Partners Stephanie Philbin Tekla Capital Management LLC Vicente Nunez
Author: Georgio Naffaa
…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here